S4449
Seppro® Neutralization Buffer
Synonym(s):
Tris (hydroxymethyl) aminomethane buffer
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
compatibility
for use with ABI ViiA 7
storage temp.
2-8°C
General description
Seppro® Neutralization buffer [Tris (hydroxymethyl) aminomethane] is a reagent qualified for use in Seppro® protein preparation and separation systems.
Application
Seppro® neutralization buffer has been used to neutralize the column for immunoglobulin Y (IgY) immunodepletion of top abundant plasma proteins. It has also been used for IgY14 and SuperMix depletion of human plasma.
Legal Information
Seppro is a registered trademark of Merck KGaA, Darmstadt, Germany
Storage Class Code
12 - Non Combustible Liquids
WGK
WGK 1
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Nature protocols, 12(8), 1683-1701 (2017-07-28)
Proteomic characterization of blood plasma is of central importance to clinical proteomics and particularly to biomarker discovery studies. The vast dynamic range and high complexity of the plasma proteome have, however, proven to be serious challenges and have often led
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 939, 10-16 (2013-10-05)
Human plasma is a commonly used diagnostic fluid in clinical chemistry. In-depth plasma proteomic analysis is performed to search for disease biomarkers, however the large dynamic range of protein abundance in plasma presents a substantial analytical challenge. Removal of abundant
Methods in molecular biology (Clifton, N.J.), 728, 29-46 (2011-04-07)
Serum- and plasma-based biomarker discovery requires technologies with specific capabilities: sufficient proteome coverage and depth, technical reproducibly, and the scalability to enable analysis on a large number of samples at reasonable cost. We have shown that plasma samples processed using
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service